Development asset linked to BELPHARMA in public FDA and regional records.
pharma · Apnea of Prematurity · Safety and Pharmacokinetics
BELPHARMA
Belpharma s.a.
BELPHARMA drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Company details
- Status
- Public
- HQ
- Luxembourg, LU
- Founded
- 2011
- Employees
- 16
- Programs
- 3
- Drugs
- 2
- Patents
- 0
BELPHARMA pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
BELPHARMA drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to BELPHARMA in public FDA and regional records.